Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.

The Duke Global Health Institute on Wednesday hosted "From Marlboro to Meta: Combatting the Health Impacts of Market-Driven ...

Are you stressed out with your emotions running high? Understand how your ADHD brain regulates your emotions, and learn ...